Efficacy of some avian influenza H5 vaccines against local highly pathogenic avian influenza viruses subtype H5N8 isolated in 2018 and 2020 in Egypt
Commercial inactivated avian influenza H5 vaccine is used as an essential control strategy for avian influenza disease in Egypt. Since the initial outbreaks of highly pathogenic avian influenza H5N8, the virus has diverged with new genotypes and variant viruses continuing to emerge which mainly stan...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Finlay Ediciones
2023-02-01
|
| Series: | VacciMonitor |
| Subjects: | |
| Online Access: | http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2023000100003&lng=es&nrm=iso&tlng=en |
| _version_ | 1797902558243586048 |
|---|---|
| author | Mounir M Elsafty Alaa RI Morsy Marwa Fathy Elsayed Reem A Soliman Mahmoud M Abotaleb |
| author_facet | Mounir M Elsafty Alaa RI Morsy Marwa Fathy Elsayed Reem A Soliman Mahmoud M Abotaleb |
| author_sort | Mounir M Elsafty |
| collection | DOAJ |
| description | Commercial inactivated avian influenza H5 vaccine is used as an essential control strategy for avian influenza disease in Egypt. Since the initial outbreaks of highly pathogenic avian influenza H5N8, the virus has diverged with new genotypes and variant viruses continuing to emerge which mainly stand behind vaccination failure. In the present work, four different commercial avian influenza vaccines were inoculated in specific pathogenic free chickens for assessing its efficacy against local highly pathogenic avian influenza H5N8 virus isolated in 2018 and 2020. Two hundred and forty specific pathogenic free chickens were clustered into four groups; each group was inoculated with the corresponding vaccine (60 specific pathogenic free chickens/vaccine). Sixty specific pathogenic free chicks were kept as control unvaccinated group. Sera collected from vaccinated chicken groups at 3rd and 4th week post vaccination were examined for calculating neutralizing antibodies using heterologous highly pathogenic avian influenza H5N8 2018 and 2020. At 4th week post vaccination, vaccinated chickens were challenged; moreover, oropharyngeal swabs were collected from challenged vaccinated chickens to calculate the viral shedding. Our findings revealed the groups vaccinated with vaccine code no 1 and 2 that contains two vaccine strains (H5N1 and H5N8) of local origin exhibited the highest hemagglutination inhibition titer, protection (%) and reduction in viral shedding titer when examined by highly pathogenic avian influenza H5N8 2018 while, vaccine code no 3 induced lower antibody response, protection (%) and reduction in viral shedding, but still within satisfactory level when compared to previous groups. When highly pathogenic avian influenza H5N8 2020 was used, it was found the seroconversion rate, protection (%) and mean titer of reduction of viral shedding decreased in comparison to those recorded for highly pathogenic avian influenza H5N8 2018. Vaccine code no 4 was impotent to either highly pathogenic avian influenza 2018 or 2020. Accordingly, it was recommended to update vaccine strain according to epidemiological condition and used the predominant circulating strain isolate in challenge test. |
| first_indexed | 2024-04-10T09:19:30Z |
| format | Article |
| id | doaj.art-2e179d733f294596be3163a5dc7e589d |
| institution | Directory Open Access Journal |
| issn | 1025-028X 1025-0298 |
| language | English |
| last_indexed | 2024-04-10T09:19:30Z |
| publishDate | 2023-02-01 |
| publisher | Finlay Ediciones |
| record_format | Article |
| series | VacciMonitor |
| spelling | doaj.art-2e179d733f294596be3163a5dc7e589d2023-02-20T14:23:48ZengFinlay EdicionesVacciMonitor1025-028X1025-02982023-02-0132Efficacy of some avian influenza H5 vaccines against local highly pathogenic avian influenza viruses subtype H5N8 isolated in 2018 and 2020 in EgyptMounir M Elsafty0https://orcid.org/0000-0003-1199-1375Alaa RI Morsy1https://orcid.org/0000-0002-5230-1812Marwa Fathy Elsayed2https://orcid.org/0000-0002-3794-9071Reem A Soliman3https://orcid.org/0000-0003-4074-4584Mahmoud M Abotaleb4https://orcid.org/0000-0001-9303-539XCentral Laboratory for Evaluation of Veterinary Biologics, Agriculture Research Center. Cairo, EgyptCentral Laboratory for Evaluation of Veterinary Biologics, Agriculture Research Center. Cairo, EgyptCentral Laboratory for Evaluation of Veterinary Biologics, Agriculture Research Center. Cairo, EgyptCentral Laboratory for Evaluation of Veterinary Biologics, Agriculture Research Center. Cairo, EgyptCentral Laboratory for Evaluation of Veterinary Biologics, Agriculture Research Center. Cairo, EgyptCommercial inactivated avian influenza H5 vaccine is used as an essential control strategy for avian influenza disease in Egypt. Since the initial outbreaks of highly pathogenic avian influenza H5N8, the virus has diverged with new genotypes and variant viruses continuing to emerge which mainly stand behind vaccination failure. In the present work, four different commercial avian influenza vaccines were inoculated in specific pathogenic free chickens for assessing its efficacy against local highly pathogenic avian influenza H5N8 virus isolated in 2018 and 2020. Two hundred and forty specific pathogenic free chickens were clustered into four groups; each group was inoculated with the corresponding vaccine (60 specific pathogenic free chickens/vaccine). Sixty specific pathogenic free chicks were kept as control unvaccinated group. Sera collected from vaccinated chicken groups at 3rd and 4th week post vaccination were examined for calculating neutralizing antibodies using heterologous highly pathogenic avian influenza H5N8 2018 and 2020. At 4th week post vaccination, vaccinated chickens were challenged; moreover, oropharyngeal swabs were collected from challenged vaccinated chickens to calculate the viral shedding. Our findings revealed the groups vaccinated with vaccine code no 1 and 2 that contains two vaccine strains (H5N1 and H5N8) of local origin exhibited the highest hemagglutination inhibition titer, protection (%) and reduction in viral shedding titer when examined by highly pathogenic avian influenza H5N8 2018 while, vaccine code no 3 induced lower antibody response, protection (%) and reduction in viral shedding, but still within satisfactory level when compared to previous groups. When highly pathogenic avian influenza H5N8 2020 was used, it was found the seroconversion rate, protection (%) and mean titer of reduction of viral shedding decreased in comparison to those recorded for highly pathogenic avian influenza H5N8 2018. Vaccine code no 4 was impotent to either highly pathogenic avian influenza 2018 or 2020. Accordingly, it was recommended to update vaccine strain according to epidemiological condition and used the predominant circulating strain isolate in challenge test.http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2023000100003&lng=es&nrm=iso&tlng=enavian influenzaserological testsinfluenza vaccineshumoral immune response |
| spellingShingle | Mounir M Elsafty Alaa RI Morsy Marwa Fathy Elsayed Reem A Soliman Mahmoud M Abotaleb Efficacy of some avian influenza H5 vaccines against local highly pathogenic avian influenza viruses subtype H5N8 isolated in 2018 and 2020 in Egypt VacciMonitor avian influenza serological tests influenza vaccines humoral immune response |
| title | Efficacy of some avian influenza H5 vaccines against local highly pathogenic avian influenza viruses subtype H5N8 isolated in 2018 and 2020 in Egypt |
| title_full | Efficacy of some avian influenza H5 vaccines against local highly pathogenic avian influenza viruses subtype H5N8 isolated in 2018 and 2020 in Egypt |
| title_fullStr | Efficacy of some avian influenza H5 vaccines against local highly pathogenic avian influenza viruses subtype H5N8 isolated in 2018 and 2020 in Egypt |
| title_full_unstemmed | Efficacy of some avian influenza H5 vaccines against local highly pathogenic avian influenza viruses subtype H5N8 isolated in 2018 and 2020 in Egypt |
| title_short | Efficacy of some avian influenza H5 vaccines against local highly pathogenic avian influenza viruses subtype H5N8 isolated in 2018 and 2020 in Egypt |
| title_sort | efficacy of some avian influenza h5 vaccines against local highly pathogenic avian influenza viruses subtype h5n8 isolated in 2018 and 2020 in egypt |
| topic | avian influenza serological tests influenza vaccines humoral immune response |
| url | http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2023000100003&lng=es&nrm=iso&tlng=en |
| work_keys_str_mv | AT mounirmelsafty efficacyofsomeavianinfluenzah5vaccinesagainstlocalhighlypathogenicavianinfluenzavirusessubtypeh5n8isolatedin2018and2020inegypt AT alaarimorsy efficacyofsomeavianinfluenzah5vaccinesagainstlocalhighlypathogenicavianinfluenzavirusessubtypeh5n8isolatedin2018and2020inegypt AT marwafathyelsayed efficacyofsomeavianinfluenzah5vaccinesagainstlocalhighlypathogenicavianinfluenzavirusessubtypeh5n8isolatedin2018and2020inegypt AT reemasoliman efficacyofsomeavianinfluenzah5vaccinesagainstlocalhighlypathogenicavianinfluenzavirusessubtypeh5n8isolatedin2018and2020inegypt AT mahmoudmabotaleb efficacyofsomeavianinfluenzah5vaccinesagainstlocalhighlypathogenicavianinfluenzavirusessubtypeh5n8isolatedin2018and2020inegypt |